Detailed curriculum vitae of HER2-targeted therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference158 articles.
1. A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC);Abuhelwa;Cancer Treatment Reviews,2022
2. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth;Agus;Cancer Cell,2002
3. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial;André;The Lancet Oncology,2014
4. Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation;Anido;The EMBO Journal,2006
5. Role of ErbB receptors in cancer cell migration and invasion;Appert-Collin;Frontiers in Pharmacology,2015
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer;Aging;2024-08-23
2. Pleiotropic physiological functions of Piezo1 in human body and its effect on malignant behavior of tumors;Frontiers in Physiology;2024-04-16
3. Anti‐HER2 Immunoliposomes: Antitumor Efficacy Attributable to Targeted Delivery of Anthraquinone‐Fused Enediyne;Advanced Science;2024-02-14
4. Characterization of prevalent tyrosine kinase inhibitors and their challenges in glioblastoma treatment;Frontiers in Chemistry;2024-01-08
5. The History and Development of HER2 Inhibitors;Pharmaceuticals;2023-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3